Human Services
Patent Owner
Stats
- 0 US PATENTS IN FORCE
- 1 US APPLICATIONS PENDING
- Jul 20, 2017 most recent publication
Details
- 0 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 117 Total Citation Count
- May 05, 2003 Earliest Filing
- 7 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
| Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0202,977 POLYKETAL PARTICLES INCLUDING A CPG OLIGODEOXYNUCLEOTIDE FOR THE TREATMENT OF LUNG CANCERJul 08, 15Jul 20, 17[A61K]
Recent Patents
- No Recent Patents to Display
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2014/0024,013 Isolation, Cloning and Characterization of New Adeno-Associated Virus (AAV) SerotypesAbandonedSep 07, 12Jan 23, 14[G01N, C07K]
2011/0189,193 CELL LINES AND HOST NUCLEIC ACID SEQUENCES RELATED TO INFECTIOUS DISEASEAbandonedMar 10, 11Aug 04, 11[A61K, C12Q, C12N, G01N, A61P]
2011/0152,115 METHODS FOR IDENTIFYING, DIAGNOSING, AND PREDICTING SURVIVAL OF LYMPHOMASAbandonedJan 18, 11Jun 23, 11[C40B]
2011/0117,101 CC CHEMOKINE RECEPTOR 5 DNA, NEW ANIMAL MODELS AND THERAPEUTIC AGENTS FOR HIV INFECTIONAbandonedJan 24, 11May 19, 11[A61K, C12N, A61P]
2010/0267,712 ISOINDOLINE COMPOUNDS FOR THE TREATMENT OF SPINAL MUSCULAR ATROPHY AND OTHER USESAbandonedSep 26, 08Oct 21, 10[A61K, C07D, A61P]
2010/0255,491 MAMMALIAN SELENOPROTEIN DIFFERENTIALLY EXPRESSED IN TUMOR CELLSAbandonedJun 14, 10Oct 07, 10[C12Q]
2004/0076,619 Methods and compositions for the repair and/or regeneration of damaged myocardiumAbandonedMay 05, 03Apr 22, 04[A61K]
Top Inventors for This Owner
| Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.